Corient Private Wealth LP Takes $2.15 Million Position in Bath & Body Works, Inc. $BBWI

Key Points

• Corient Private Wealth acquired 93,001 Bath & Body Works shares during the second quarter, representing a position worth approximately $2.15 million. Institutional investors and hedge funds collectively own 95.14% of the company.
• Bath & Body Works reported quarterly EPS of $0.62, beating estimates of $0.24, while revenue reached $1.51 billion but declined 2.3% year over year. The company also declared a quarterly dividend of $0.20 per share, offering an annualized yield of about 4.3%.
• BBWI shares opened at $18.52, below the analyst consensus target of $22.29. Despite mixed analyst views, the stock carries a consensus “Hold” rating, with four Buy, thirteen Hold, and one Sell rating.

Corient Private Wealth LP acquired a new stake in shares of Bath & Body Works, Inc. (NYSE:BBWI - Free Report) during the second quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund acquired 93,001 shares of the company's stock, valued at approximately $2,153,000.

Other institutional investors have also bought and sold shares of the company. Global Retirement Partners LLC bought a new position in Bath & Body Works in the 4th quarter valued at about $31,000. Geneos Wealth Management Inc. raised its position in shares of Bath & Body Works by 217.7% during the 1st quarter. Geneos Wealth Management Inc. now owns 1,169 shares of the company's stock worth $35,000 after buying an additional 801 shares in the last quarter. Parallel Advisors LLC lifted its stake in shares of Bath & Body Works by 42.6% in the 4th quarter. Parallel Advisors LLC now owns 1,897 shares of the company's stock worth $38,000 after acquiring an additional 567 shares during the period. Danske Bank A S acquired a new stake in shares of Bath & Body Works in the 3rd quarter worth approximately $39,000. Finally, Elevation Wealth Partners LLC boosted its holdings in shares of Bath & Body Works by 5,278.8% in the second quarter. Elevation Wealth Partners LLC now owns 1,775 shares of the company's stock valued at $41,000 after acquiring an additional 1,742 shares in the last quarter. Institutional investors and hedge funds own 95.14% of the company's stock.

Bath & Body Works Price Performance

Shares of BBWI opened at $18.52 on Thursday. The firm's 50 day moving average is $20.18 and its 200-day moving average is $19.87. The stock has a market capitalization of $3.73 billion, a P/E ratio of 4.82, a P/E/G ratio of 1.93 and a beta of 1.38. Bath & Body Works, Inc. has a 12-month low of $14.27 and a 12-month high of $32.32.

Bath & Body Works (NYSE:BBWI - Get Free Report) last released its earnings results on Wednesday, August 26th. The company reported $0.62 EPS for the quarter, beating the consensus estimate of $0.24 by $0.38. The business had revenue of $1.51 billion during the quarter, compared to analyst estimates of $1.50 billion. Bath & Body Works had a net margin of 10.83% and a negative return on equity of 53.48%. The business's quarterly revenue was down 2.3% on a year-over-year basis. During the same period in the prior year, the business earned $0.30 earnings per share. Bath & Body Works has set its Q3 2026 guidance at 0.070-0.120 EPS and its FY 2026 guidance at 2.600-2.800 EPS. As a group, equities research analysts forecast that Bath & Body Works, Inc. will post 2.7 EPS for the current fiscal year.

Bath & Body Works Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, September 4th. Stockholders of record on Friday, August 21st will be given a dividend of $0.20 per share. This represents a $0.80 dividend on an annualized basis and a dividend yield of 4.3%. The ex-dividend date is Friday, August 21st. Bath & Body Works's dividend payout ratio is 20.83%.

Wall Street Analyst Weigh In

A number of research firms recently commented on BBWI. Wells Fargo & Company lowered their price objective on shares of Bath & Body Works from $26.00 to $24.00 and set an "overweight" rating on the stock in a research note on Thursday, August 27th. Citigroup upgraded Bath & Body Works from a "neutral" rating to a "buy" rating and set a $25.00 target price for the company in a research report on Tuesday, August 18th. Barclays decreased their price target on Bath & Body Works from $23.00 to $22.00 and set an "equal weight" rating for the company in a research note on Thursday, August 27th. UBS Group lowered their price target on Bath & Body Works from $19.00 to $17.00 and set a "neutral" rating on the stock in a research report on Thursday, August 27th. Finally, Piper Sandler initiated coverage on Bath & Body Works in a research note on Friday, May 15th. They issued a "neutral" rating and a $20.00 price objective on the stock. Four investment analysts have rated the stock with a Buy rating, thirteen have given a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat.com, the stock has a consensus rating of "Hold" and a consensus target price of $22.29.

Bath & Body Works Profile

Bath & Body Works, Inc is a leading specialty retailer focused on personal care, home fragrance and complementary products. Through its flagship Bath & Body Works brand, the company offers a diverse assortment of shower gels, lotions, fragrance mists, candles and home fragrance items. Its product portfolio also includes the White Barn Candle Co range of premium scented candles and diffusers. Bath & Body Works serves consumers through a combination of brick-and-mortar stores and e-commerce platforms, delivering seasonal collections, limited-edition releases and signature scent lines.

Founded in 1990 as part of Limited Brands (now L Brands), Bath & Body Works opened its first store in New Albany, Ohio, and quickly expanded across the United States.

Want to see what other hedge funds are holding BBWI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Bath & Body Works, Inc. (NYSE:BBWI - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source